New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

Highly pathogenic H5N5 avian flu has been detected in a backyard poultry flock in Newfoundland and Labrador, according to ...

Three more infections were confirmed in Gaines County, which has been the epicenter and now has 45 cases. Six more measles ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

The genome contains complex information regarding the evolution ... Using GRU networks to dissect and compare Ebola virus genomes from their sources in human patients and the wildlife reservoir, ...

U.S. health officials on Wednesday urged Americans traveling to Uganda to take precautions because of an Ebola outbreak — and said they are helping Ugandan health officials respond to the threat ...

Uganda has launched a trial of a vaccine against the Sudan strain of the Ebola virus, following an outbreak in the country with three confirmed cases. The first patient, a 32-year-old male nurse, died ...

This is the first trial to assess the clinical efficacy of a vaccine against Ebola Sudan virus disease. IAVI, the provider of the vaccine, conducted trials for safety and immunogenicity.

Uganda started a vaccination trial on Monday for the Ebola Sudan virus four days after an outbreak was confirmed, the WHO announced, beginning with those deemed at highest risk. World Health ...

The often-deadly Ebola virus disease (EVD) is confined mostly to Africa, but because of how globally connected the world is today, it is regarded as a possible health threat worldwide. Still ...